The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
about
Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell TransplantationNodular inflammatory foci are sites of T cell priming and control of murine cytomegalovirus infection in the neonatal lungIn vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infectionsPersistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirusFocal transcriptional activity of murine cytomegalovirus during latency in the lungs.Strain-specific neutralization of human cytomegalovirus isolates by human sera.In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83).The pathogenicity of cytomegalovirus.Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivoMucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell cultureMurine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency.Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection.Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungsSystematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution.Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrenceExperimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals.Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replicationProcessing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functionsReactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures.Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Early establishment of gamma-herpesvirus latency: implications for immune control.Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonatesCytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivationEstablishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infectionEvaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic micePulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungsProtracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.Cytomegalovirus Reinfections Stimulate CD8 T-Memory InflationCytomegalovirus exploits IL-10-mediated immune regulation in the salivary glandsAntibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections.
P2860
Q26740328-527829FF-30FE-47E3-9FE6-F3B47802E783Q27331441-3A716862-A016-4A40-BD39-63364D4FBBC5Q28344285-F8E61D83-B20C-4C1D-857A-EEAD6954A16DQ31050845-12D13D8F-89A5-425C-8874-C4264054DCE3Q33639571-F26AF383-2FE4-4364-A092-F3A609C6F50BQ33640031-7407EEB7-6DDD-4380-84B0-CF86CAFA0BC3Q33650230-9397F485-A9BC-49DB-9F2A-510BC3ADC7F6Q33697113-27D99712-4E7F-4BAB-B8AD-3A13609CC3B9Q33725662-3C6A094D-9DF3-43D4-AEAE-5402C2273B93Q33782029-5AB64B6C-FAD4-4B55-B1B3-5BA48EBE67EDQ33782273-9E12AA85-4B3F-4048-9663-E3EA5F9D05C4Q33788669-1E959069-963F-446D-BE4E-89F5E9BC340DQ33808932-3F983CCD-9E0B-40CF-9233-0E53C5E4DC1CQ33809769-0848CB60-0B1B-45D2-91CE-65816A0DA80FQ33812288-6682168F-D34A-4EA1-81A6-95144F8C6D05Q33818345-B6450323-0FB8-4C82-93A1-17749A0A1EE4Q33820723-50419AED-74C4-41E8-8AE4-1E1B75F3B706Q33843590-6C9ABD83-15AB-4A5A-BD45-37D9FF7D5EB8Q33865510-4EEE1948-B04F-44AA-8748-37FF391BD463Q34166586-6AF6EE8E-C8CE-4C66-AA41-5E99B7A33C74Q34327234-794C8B00-7702-4837-99BC-CB7D2F57429AQ34338715-3ACA710D-6E70-4DF0-B123-6E713DED65A5Q34339686-DF231BD3-166D-4E02-8634-AA10F5EC2746Q34342396-741203B0-701D-4B5B-99FA-F02C070D9B5EQ34346013-6BE77ECA-92CA-4118-B6D4-5D5851EE9E1CQ34360228-B80224DE-BC6A-482C-A13B-D5C6BB2F7139Q34755942-ECED1027-ED75-48E1-B661-867AC84A4852Q35076650-1A4A127A-CDDE-48C1-B40A-3B20EAE91F8AQ35086196-0F0CD18A-80A2-4900-A589-B67E6312D126Q35139332-74904D00-B29A-492F-8D47-DE081EE9A897Q35149326-3C992D63-D327-4D67-900A-4762898D95E5Q35693349-35FCC38F-89AF-42D9-9536-3C5196F83C13Q35786286-193B94CE-D6A0-4B53-8B59-5C69AC3B0CBAQ35846755-79061481-8482-486F-BB34-146637406971Q35880904-9CD07710-DA29-49CF-8D93-D0241C8FC6DCQ35914479-73CD81F3-8E40-473A-BED0-92A480728185Q36199934-3E0280E6-A864-4106-B27C-BD200EBC63C0Q36229323-9ADD1115-8192-4EDC-BC9D-0FCF6D3834A9Q36363051-5FF81EE7-BCF5-4D5F-A6E4-855B9826B9E6Q36528054-C882EB62-AA00-4303-BAE5-EF49CD135DE5
P2860
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The conditions of primary infe ...... rrent cytomegalovirus disease.
@en
type
label
The conditions of primary infe ...... rrent cytomegalovirus disease.
@en
prefLabel
The conditions of primary infe ...... rrent cytomegalovirus disease.
@en
P2093
P2860
P356
P1476
The conditions of primary infe ...... urrent cytomegalovirus disease
@en
P2093
M Balthesen
M J Reddehase
U H Koszinowski
P2860
P304
P356
10.1084/JEM.179.1.185
P407
P577
1994-01-01T00:00:00Z